Methylphenidate for ADHD in Children and Adolescents

The therapeutic effectiveness of methylphenidate (MPH) (0.3 mg/kg) in attention-deficit hyperactivity disorder (ADHD) was compared during childhood (ages 8 to 11 years) and adolescence (ages 12 to 14.5 years) in a retrospective follow-up study of 16 patients who had completed double-blind, placebo-c...

Full description

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Published: Pediatric Neurology Briefs Publishers 1998-03-01
Series:Pediatric Neurology Briefs
Online Access: